Understanding of the well-characterized mechanism of decreased sensitivity of cancer cells to tubulin-binding agents (TBAs) like vinca alkaloids and taxanes, comes from the analysis of TUBB3 and TUBB4B level regulation in non-small cell lung cancer and prostate cancer development [12,13,14,15,16]. Here, TUBB4B is linked to cancer.